Sheng-Chieh Hsu

2.3k total citations · 2 hit papers
16 papers, 1.7k citations indexed

About

Sheng-Chieh Hsu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sheng-Chieh Hsu has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sheng-Chieh Hsu's work include HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sheng-Chieh Hsu is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Sheng-Chieh Hsu collaborates with scholars based in Taiwan, United States and Canada. Sheng-Chieh Hsu's co-authors include Mien‐Chie Hung, Hui‐Wen Lo, Weiya Xia, Jin‐Yuan Shih, Gabriel N. Hortobágyi, Xinyu Cao, Yongkun Wei, James L. Abbruzzese, Hsing-Jien Kung and David K. Ann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Sheng-Chieh Hsu

16 papers receiving 1.7k citations

Hit Papers

Epidermal Growth Factor Receptor Cooperates with Signal T... 2007 2026 2013 2019 2007 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng-Chieh Hsu Taiwan 16 1.0k 811 364 286 151 16 1.7k
Sergej Skvortsov Austria 24 1.2k 1.2× 780 1.0× 605 1.7× 332 1.2× 197 1.3× 48 2.1k
Alexei V. Salnikov Germany 17 870 0.8× 802 1.0× 433 1.2× 153 0.5× 183 1.2× 23 1.6k
Wendy J. Huss United States 22 981 0.9× 711 0.9× 497 1.4× 664 2.3× 202 1.3× 40 1.8k
Sven A. Lang Germany 24 928 0.9× 449 0.6× 298 0.8× 174 0.6× 218 1.4× 44 1.5k
Erzsébet Rásó Hungary 29 1.1k 1.0× 840 1.0× 501 1.4× 409 1.4× 220 1.5× 90 2.2k
Jonas Cicenas Switzerland 17 921 0.9× 684 0.8× 383 1.1× 254 0.9× 92 0.6× 28 1.5k
Nina V. Chaika United States 22 1.1k 1.0× 661 0.8× 662 1.8× 180 0.6× 154 1.0× 32 1.8k
Jennifer L. Wilding United Kingdom 17 974 0.9× 767 0.9× 467 1.3× 183 0.6× 144 1.0× 24 1.9k
Carolyn Cao United States 18 1.3k 1.2× 709 0.9× 402 1.1× 290 1.0× 118 0.8× 30 1.9k
Shou‐Ching Tang United States 24 1.3k 1.2× 542 0.7× 504 1.4× 230 0.8× 175 1.2× 85 1.8k

Countries citing papers authored by Sheng-Chieh Hsu

Since Specialization
Citations

This map shows the geographic impact of Sheng-Chieh Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng-Chieh Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng-Chieh Hsu more than expected).

Fields of papers citing papers by Sheng-Chieh Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng-Chieh Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng-Chieh Hsu. The network helps show where Sheng-Chieh Hsu may publish in the future.

Co-authorship network of co-authors of Sheng-Chieh Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng-Chieh Hsu. A scholar is included among the top collaborators of Sheng-Chieh Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng-Chieh Hsu. Sheng-Chieh Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chen, Chia‐Lin, Sheng-Chieh Hsu, Pei‐Wen Hsiao, et al.. (2021). Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells. Nature Communications. 12(1). 2398–2398. 77 indexed citations
2.
Hsu, Sheng-Chieh, Chia‐Lin Chen, Mei‐Ling Cheng, et al.. (2021). Arginine starvation elicits chromatin leakage and cGAS-STING activation via epigenetic silencing of metabolic and DNA-repair genes. Theranostics. 11(15). 7527–7545. 36 indexed citations
3.
Chen, Chia‐Lin, Sheng-Chieh Hsu, David K. Ann, Yun Yen, & Hsing-Jien Kung. (2021). Arginine Signaling and Cancer Metabolism. Cancers. 13(14). 3541–3541. 173 indexed citations breakdown →
4.
Wang, Hung-Jung, Jen‐Sing Liu, Sheng-Chieh Hsu, et al.. (2019). Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation. Communications Biology. 2(1). 105–105. 19 indexed citations
5.
Wu, Chung‐Pu, Chia‐Hung Hsieh, Shiyu Luo, et al.. (2015). Human ATP-Binding Cassette Transporter ABCB1 Confers Resistance to Volasertib (BI 6727), a Selective Inhibitor of Polo-like Kinase 1. Molecular Pharmaceutics. 12(11). 3885–3895. 29 indexed citations
6.
Huang, Wei‐Chien, Chao-Ming Hung, Lei-Chin Chen, et al.. (2013). BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib. PLoS ONE. 8(12). e83627–e83627. 66 indexed citations
7.
Huang, Wei‐Chien, Yun‐Ju Chen, Long‐Yuan Li, et al.. (2011). Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells. Journal of Biological Chemistry. 286(23). 20558–20568. 144 indexed citations
8.
Chen, Yun‐Ju, Wei‐Chien Huang, Ya-Ling Wei, et al.. (2011). Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells. PLoS ONE. 6(6). e21428–e21428. 69 indexed citations
9.
Song, Hui, Chia‐Wei Li, Adam M. LaBaff, et al.. (2010). Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. Biochemical and Biophysical Research Communications. 404(1). 68–73. 34 indexed citations
10.
Huo, Longfei, Ying‐Nai Wang, Weiya Xia, et al.. (2010). RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus. Proceedings of the National Academy of Sciences. 107(37). 16125–16130. 89 indexed citations
12.
Hsu, Sheng-Chieh & Mien‐Chie Hung. (2007). Characterization of a Novel Tripartite Nuclear Localization Sequence in the EGFR Family. Journal of Biological Chemistry. 282(14). 10432–10440. 198 indexed citations
13.
Lo, Hui‐Wen, Sheng-Chieh Hsu, Weiya Xia, et al.. (2007). Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression. Cancer Research. 67(19). 9066–9076. 526 indexed citations breakdown →
14.
Lo, Hui‐Wen, Sheng-Chieh Hsu, & Mien‐Chie Hung. (2005). EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Research and Treatment. 95(3). 211–218. 186 indexed citations
15.
Huang, Yi‐Hsiang, Jaw‐Ching Wu, Sheng-Chieh Hsu, & Wan‐Jr Syu. (2003). VariedImmunity Generated in Mice by DNA Vaccines with Large and SmallHepatitis DeltaAntigens. Journal of Virology. 77(24). 12980–12985. 15 indexed citations
16.
Huang, Yi‐Hsiang, Jaw‐Ching Wu, Mi‐Hua Tao, et al.. (2000). DNA-based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model. Hepatology. 32(1). 104–110. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026